Transcranial Direct Current Stimulation Therapy for Bipolar Depression
Community-based Transcranial Direct Current Stimulation Treatment for Bipolar Depression
1 other identifier
interventional
44
1 country
1
Brief Summary
Bipolar disorder is a severe and disabling disorder. The course of illness is often progressive but is highly heterogeneous between individuals and within the lifetime for an individual. The most common treatments are medications. However, for many individuals, combinations of medications are often required, and full recovery is infrequent. The novel brain stimulation treatment, transcranial direct current stimulation (tDCS), is a potential first-line treatment for bipolar depression. The present research question is whether tDCS can be provided as a home-based treatment for bipolar depression for adults with bipolar disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedFirst Submitted
Initial submission to the registry
June 23, 2022
CompletedFirst Posted
Study publicly available on registry
June 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedResults Posted
Study results publicly available
August 14, 2025
CompletedAugust 14, 2025
July 1, 2025
2.1 years
June 23, 2022
June 16, 2025
July 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Clinical Response [ Time Frame: At 6 Weeks Following Course of tDCS Treatment ]
As measured by clinician-rated Montgomery Asberg Depression Rating Scale (MADRS) score improvement of 50% or more from baseline following the course of tDCS treatment.
6 weeks
Secondary Outcomes (2)
Participant Retention at the End of the Treatment
6 weeks (visit 21)
Participant Acceptability Questionnaire Scales
Week 6 (Visit 21)
Other Outcomes (1)
MADRS Remission Rate
6 weeks (Visit 21)
Study Arms (1)
Device: transcranial direct current stimulation
EXPERIMENTAL6-week course of active tDCS treatment, consisting of 5 sessions per week for the first 3 weeks followed by 2 sessions per week for 3 weeks, for a total of 21 tDCS sessions. The duration of each session is 30 minutes.
Interventions
tDCS at 2mA in 30 minute sessions for 5 sessions per week for 3 weeks and then 2 sessions per week for 3 weeks.
Eligibility Criteria
You may qualify if:
- diagnosis of bipolar disorder based on DSM-5 criteria
- minimum score of 18 on the MADRS
- being on a stable dosage of mood stabilizing medication for a minimum of two weeks
You may not qualify if:
- comorbid psychiatric disorder
- significant risk of suicide or self harm
- any contraindications to tDCS, including implanted electronic medical devices
- history of epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of East Londonlead
- University College, Londoncollaborator
- King's College Londoncollaborator
- Technische Universität Dresdencollaborator
Study Sites (1)
University of East London
London, E16 2RD, United Kingdom
Related Publications (7)
Mutz J, Edgcumbe DR, Brunoni AR, Fu CHY. Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: A systematic review and meta-analysis of randomised sham-controlled trials. Neurosci Biobehav Rev. 2018 Sep;92:291-303. doi: 10.1016/j.neubiorev.2018.05.015. Epub 2018 May 12.
PMID: 29763711BACKGROUNDMutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ. 2019 Mar 27;364:l1079. doi: 10.1136/bmj.l1079.
PMID: 30917990BACKGROUNDWoodham R, Rimmer RM, Mutz J, Fu CHY. Is tDCS a potential first line treatment for major depression? Int Rev Psychiatry. 2021 May;33(3):250-265. doi: 10.1080/09540261.2021.1879030. Epub 2021 Mar 11.
PMID: 33706656BACKGROUNDWoodham RD, Rimmer RM, Young AH, Fu CHY. Adjunctive home-based transcranial direct current stimulation treatment for major depression with real-time remote supervision: An open-label, single-arm feasibility study with long term outcomes. J Psychiatr Res. 2022 Sep;153:197-205. doi: 10.1016/j.jpsychires.2022.07.026. Epub 2022 Jul 8.
PMID: 35839661BACKGROUNDRezaei H, Woodham RD, Ghazi-Noori AR, Ritter P, Bauer M, Young AH, Bramon E, Fu CHY. Acceptability of home-based transcranial direct current stimulation (tDCS) in bipolar depression: thematic analysis of individual views. BMC Psychiatry. 2025 May 26;25(1):549. doi: 10.1186/s12888-025-06948-4.
PMID: 40420071DERIVEDRezaei H, Woodham RD, Ghazi-Noori AR, Ritter P, Bauer M, Young AH, Bramon E, Fu CHY. Acceptability of Home-Based Transcranial Direct Current Stimulation (tDCS) in Bipolar Depression: Thematic Analysis of Individual Views. Res Sq [Preprint]. 2025 Apr 15:rs.3.rs-5967699. doi: 10.21203/rs.3.rs-5967699/v1.
PMID: 40321750DERIVEDGhazi-Noori AR, Woodham RD, Rezaei H, Sharif MS, Bramon E, Ritter P, Bauer M, Young AH, Fu CHY. Home-based transcranial direct current stimulation in bipolar depression: an open-label treatment study of clinical outcomes, acceptability and adverse events. Int J Bipolar Disord. 2024 Aug 20;12(1):30. doi: 10.1186/s40345-024-00352-9.
PMID: 39162912DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Professor Cynthia Fu
- Organization
- University of East Lonson
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia Fu, MD, PhD
University of East London
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- College Professor of Affective Neuroscience
Study Record Dates
First Submitted
June 23, 2022
First Posted
June 29, 2022
Study Start
May 1, 2022
Primary Completion
May 30, 2024
Study Completion
May 30, 2024
Last Updated
August 14, 2025
Results First Posted
August 14, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share